Complete blockade of the FGF2 and activin A response pathways in hESC, will undoubtedly enhance our ability to guide hESC and iPSC to TB more uniformly (see “Is TB derived from BMP4-treated hESC and iPSC a mesoderm derivative?”). The gene discussed is BMP4; the disease is tuberculosis.